Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Poor-prognosis acute lymphoblastic leukemias

M Weil, C Jacquillat, M F Auclerc

    Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Proposals for a Phenotypic Classification of B-Chronic Lymphocytic Leukemia, Relationship with Prognostic Factors.

    Leukemia & lymphoma·2016
    Same author

    Pathology underrates colon cancer extranodal and nodal metastases; ex vivo radioimmunodetection helps staging.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2007
    Same author

    Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trial.

    Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2003
    Same author

    Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phase.

    Leukemia·2002
    Same author

    Prognostic relevance of a scoring system based on clinical and biological parameters in early chronic lymphocytic leukemia.

    The hematology journal : the official journal of the European Haematology Association·2002
    Same author

    Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination.

    Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2002

    Burkitt's-type leukemias and Class III acute lymphoblastic leukemia in children have poor prognoses due to relapses. A new intensive therapy protocol shows promise for improving outcomes in high-risk leukemia patients.

    Area of Science:

    • Hematology
    • Pediatric Oncology
    • Leukemia Research

    Background:

    • Burkitt's-type leukemias and Class III acute lymphoblastic leukemia (ALL) in children present unique challenges.
    • These leukemias often feature abdominal tumors and central nervous system (CNS) involvement.
    • Despite intensive treatments like high-dose cyclophosphamide, outcomes remain poor due to incomplete remission and early relapses, particularly CNS relapses.

    Purpose of the Study:

    • To evaluate a novel phase I protocol for increased-risk leukemias.
    • To assess the efficacy of intensive therapy incorporating specific strategies for high-risk pediatric leukemias.
    • To explore methods for improving complete remission rates and reducing relapse frequency in challenging leukemia subtypes.

    Main Methods:

    Related Experiment Videos

  • Implementation of a phase I protocol for increased-risk leukemias.
  • Inclusion of testicular preventive irradiation.
  • Monthly reinduction therapy without continuous maintenance for the initial 6 months of complete remission (CR).
  • Utilizing Cox's multifactorial analysis for improved patient stratification.

    • Main Results:

    • The described protocol for increased-risk leukemias appears promising.
    • Intensive therapy approaches have shown progress in treating Class III ALL.
    • Cox's multifactorial analysis aids in better patient outcome discrimination.

    Conclusions:

    • The novel phase I protocol warrants further investigation for its potential to improve outcomes in high-risk leukemias.
    • Intensive treatment strategies, including specific prophylactic measures, may enhance remission rates and reduce relapses.
    • Further research is needed to validate these findings and optimize treatment protocols for pediatric leukemias with poor prognostic factors.